A randomized, placebo-controlled, double-blind trial of augmentation of clozapine with risperidone

被引：0
|
作者：
Honer, W [1 ]
MacEwan, GW [1 ]
Williams, R [1 ]
Falkai, P [1 ]
McKenna, PJ [1 ]
Pomarol-Clotet, E [1 ]
Chen, EY [1 ]
Leung, SP [1 ]
Wong, J [1 ]
Stip, E [1 ]
机构：
[1] Univ British Columbia, Ctr Complex Disorders, Vancouver, BC V5Z 1M9, Canada
来源：
SCHIZOPHRENIA BULLETIN | 2005年 / 31卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：487 / 487
页数：1
相关论文
共 50 条
  • [1] Risperidone augmentation for schizophrenia partially responsive to clozapine: A double-blind, placebo-controlled trial
    Freudenreich, Oliver
    Henderson, David C.
    Walsh, Jared P.
    Culhane, Melissa A.
    Goff, Donald C.
    [J]. SCHIZOPHRENIA RESEARCH, 2007, 92 (1-3) : 90 - 94
  • [2] Clozapine augmented with risperidone in the treatment of schizophrenia: A randomized, double-blind, placebo-controlled trial
    Josiassen, RC
    Joseph, A
    Kohegyi, E
    Stokes, S
    Dadvand, M
    Paing, WW
    Shaughnessy, RA
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (01): : 130 - 136
  • [3] Augmentation with risperidone in chronic resistant depression: A double-blind placebo-controlled maintenance trial
    Nemeroff, CB
    Gharabawi, GM
    Canuso, CM
    Mahmoud, R
    Loescher, A
    Turkoz, I
    Rapaport, MH
    Gharabawi, GM
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S159 - S159
  • [4] Double-Blind, Randomized, Placebo-Controlled Trial of Metoclopramide for Hypersalivation Associated With Clozapine
    Kreinin, Anatoly
    Miodownik, Chanoch
    Mirkin, Vitaly
    Gaiduk, Yulia
    Yankovsky, Yan
    Bersudsky, Yuly
    Lerner, Paul P.
    Bergman, Joseph
    Lerner, Vladimir
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (03) : 200 - 205
  • [5] A double-blind placebo-controlled trial of risperidone in autistic disorder
    McDougle, C
    Aman, MG
    McCracken, JT
    Scahill, L
    Tierney, E
    Vitiello, B
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S327 - S328
  • [6] Clonidine augmentation in patients with schizophrenia: A double-blind, randomized placebo-controlled trial
    Kruiper, Caitlyn
    Sommer, Iris E. C.
    Koster, Michiel
    Bakker, P. Roberto
    Durston, Sarah
    Oranje, Bob
    [J]. SCHIZOPHRENIA RESEARCH, 2023, 255 : 148 - 154
  • [7] Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study
    Muscatello, M. R. A.
    Bruno, A.
    Pandolfo, G.
    Mico, U.
    Bellinghieri, P. M.
    Scimeca, G.
    Cacciola, M.
    Campolo, D.
    Settineri, S.
    Zoccali, R.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (05) : 667 - 674
  • [8] Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial
    Barnes, Thomas R. E.
    Leeson, Verity
    Paton, Carol
    Marston, Louise
    Osborn, David P.
    Kumar, Raj
    Keown, Patrick
    Zafar, Rameez
    Iqbal, Khalid
    Singh, Vineet
    Fridrich, Pavel
    Fitzgerald, Zachary
    Bagalkote, Hemant
    Haddad, Peter M.
    Husni, Mariwan
    Amos, Tim
    [J]. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2018, 8 (07) : 185 - 197
  • [9] Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial
    Assion, H. -J.
    Reinbold, H.
    Lemanski, S.
    Basilowski, M.
    Juckel, G.
    [J]. PHARMACOPSYCHIATRY, 2008, 41 (01) : 24 - 28
  • [10] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    [J]. OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
12345